ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.58
0.14%
US Tech 100
17,618.80
0.05%
S&P 500
5,187.70
0.13%
US Dollar vs CAD
1.37552
0.16%
Bitcoin
62,663.98
0.53%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. CNS Pharmaceuticals Inc (CNSP)

  7. CNS Pharmaceuticals Inc (CNSP) News

CNSP CNS Pharmaceuticals Inc

0.23
0.028 (13.86%)
May 07 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
CNS Pharmaceuticals Inc CNSP NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.028 13.86% 0.23 17:09:00
Open Price Low Price High Price Close Price Previous Close
0.21 0.202 0.23 0.217 0.202
more quote information »

Recent News

Date Time Source Heading
5/07/202416:00EDGAR2Form 8-K - Current report
2/27/202416:15EDGAR2Form 8-K - Current report
2/21/202416:00EDGAR2Form 8-K - Current report
2/06/202409:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/06/202409:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/06/202409:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/06/202409:26EDGAR2Form 3 - Initial statement of beneficial ownership of..
2/02/202416:00EDGAR2Form 8-K - Current report
1/31/202415:27EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
1/23/202415:01EDGAR2Form 8-K - Current report
1/22/202405:02EDGAR2Form S-1/A - General form for registration of securities..
1/10/202416:26EDGAR2Form S-1/A - General form for registration of securities..
12/21/202308:15EDGAR2Form 8-K - Current report
12/18/202307:36EDGAR2Form 8-K - Current report
12/08/202316:28EDGAR2Form S-1 - General form for registration of securities under..
11/30/202316:20EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/20/202316:26EDGAR2Form S-3 - Registration statement under Securities Act of..
11/15/202307:00EDGAR2Form 8-K - Current report
10/18/202308:00EDGAR2Form 8-K - Current report
10/17/202307:00EDGAR2Form 8-K - Current report
9/25/202317:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/25/202317:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/25/202317:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/25/202317:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/25/202317:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/18/202316:25EDGAR2Form 8-K - Current report
8/15/202307:30EDGAR2Form 8-K - Current report
8/14/202316:12EDGAR2Form DEF 14A - Other definitive proxy statements
8/14/202308:25EDGAR2Form 8-K - Current report
8/14/202306:34EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Your Recent History

NASDAQ
CNSP
CNS Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved